论文部分内容阅读
目的探讨幽门螺杆菌相关性萎缩性胃炎采用泮托拉唑、枸橼酸铋钾、阿莫西林联合治疗的效果。方法 80例幽门螺杆菌相关性萎缩性胃炎患者随机分为对照组和观察组,就奥美拉唑、甲硝唑、阿莫西林治疗(对照组,40例)与泮托拉唑、阿莫西林、枸橼酸铋钾治疗(观察组,40例)效果展开对比。结果观察组总有效率为87.5%,对照组为62.5%,两组比较差异有统计学意义(P<0.05)。观察组Hp清除率为90%,高于对照组85%。结论幽门螺杆菌相关性萎缩性胃炎采用泮托拉唑、枸橼酸铋钾、阿莫西林治疗,可显著提高临床效果,增强Hp清除效果,确保预后改善。
Objective To investigate the effect of combination therapy of pantoprazole, bismuth potassium citrate and amoxicillin in Helicobacter pylori associated atrophic gastritis. Methods Eighty patients with Helicobacter pylori-related atrophic gastritis were randomly divided into control group and observation group. Omeprazole, metronidazole, amoxicillin (control group, 40 cases) and pantoprazole, Xilin, bismuth potassium citrate treatment (observation group, 40 cases) the effect of contrast. Results The total effective rate was 87.5% in the observation group and 62.5% in the control group, with significant difference between the two groups (P <0.05). Observation group Hp clearance rate was 90%, 85% higher than the control group. Conclusion Helicobacter pylori associated atrophic gastritis with pantoprazole, bismuth potassium citrate, amoxicillin treatment, can significantly improve the clinical effect, enhance Hp removal, to ensure that the prognosis.